CAR-T Research – Lymphoma Coalition

Home / Treatment & Side Effects / News / CAR-T Research

Side-Effects in Relapsed Large...

Presented at the 65th ASH Annual Meeting and Exposition from 9-12 December 2023, in San Diego, California. The identification of side-effects associated with a particular therapy relies on univariable assessments...

Demographic Barriers to Clinical...

Presented at the 49th Annual European Society for Blood and Marrow Transplantation (EBMT) meeting, in Paris France, 22-26 April 2023. Lymphoma Coalition (LC) supports almost 90 patient organizations across more...

Side-Effect Incidence in CAR-T...

Presented at the 6th EBMT-EHA CAR-T Cell Meeting from 15-17 February 2023 in Valencia, Spain. Lymphoma Coalition (LC) supports over 90 member organizations across 54 countries. LC’s overarching vision is...

Psychosocial Experiences in Relapsed/Refractory...

Presented during the “Best Abstract Session” at the 5th European CAR-T Cell Meeting in Rotterdam, The Netherlands, February 9-11. Chimeric antigen receptor T-cell (CAR-T) therapy continues to expand as a...